Penzenstadler L

Faculty of Medicine, University of Geneva, Geneva, Switzerland.

7 papers · 2 preprints · ORCID

ArticlePsilocybin

Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.

Eskinazi M, Nasserdine R, Cusin RM +19

Europe PMC2026
ArticlePsilocybin

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.

Sabé M, Grof P, Sackett NB +24

Europe PMC2026
ArticlePsilocybin

Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland.

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2026
PreprintPsilocybin

Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland

Aboulafia-Brakha T, Buchard A, Mabilais C +11

Europe PMC2025
PreprintPsilocybin

Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement

Buchard A, Seragnoli F, Sabe M +8

Europe PMC2025
ArticlePsilocybin

[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]

Sabé M, Seragnoli F, Penzenstadler L +1

Europe PMC2025
ArticlePsilocybin

[Treatment with psychedelics : potential benefits in Parkinson's disease].

Penzenstadler L, Baudois S, Lingenberg A +3

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report.

Fleury V, Tomkova E, Catalano Chiuvé S +1

Europe PMC2025
ArticlePsilocybin

Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.

Sabé M, Sulstarova A, Glangetas A +15

Europe PMC2025